Willem Hassel - Amgen Independent Vice Chairman of the Supervisory Board
AMG Stock | EUR 264.15 1.00 0.38% |
Chairman
Mr. Willem van Hassel was appointed Vice Chairman of the Supervisory Board of AMG Advanced Metallurgical Group N.V., effective as of May 2, 2018. He has served as Member of the Supervisory Board of the Company. He obtained his Law Degree at Erasmus University Rotterdam in 1964. Until 2000, for nearly 30 years, Mr. van Hassel has practised in various legal areas, amongst which company law in general, mergers and acquisitions, shareholders and board room disputes, reorganisations and bankruptcy cases, structuring of publicprivate partnerships and privatizations. During his legal career he has always combined his counseling activities with litigation, both in court cases and arbitration. He has acted as counsel to Dutch Parliament as well as the Dutch Accounting Office. In the early 1990s, he was president of the Netherlands Bar Association. During the last four years of his legal career he was chairman and managing partner of Trenit Van Doorne, at the time one of the Dutch leading law firms. Until 2000 he was also a Deputy Judge with the Rotterdam District Court. Furthermore Mr. van Hassel gets appointments by the Enterprise Chamber of the Court of Appeals in Amsterdam as an independent investigator temporary board member in mismanagement suits and shareholders deadlocks. In various capacities he is actively involved with the developments in the field of good governance. He is also editor of the Toolkit Commissariaat and serves and has served on various supervisory boards, including Eurocommercial Properties NV until recently. Mr. van Hassel furthermore served on the Board of the Foundation Continuity AMG until March 12th, 2017 when he resigned to prepare for his nomination for AMGs Supervisory Board. since 2018.
Age | 73 |
Tenure | 6 years |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jackson Dunckel, Member of the Management Board, Chief Financial Officer | ||
Michele Fischer, Vice President IR Contact Officer | ||
Heinz Schimmelbusch, Chairman of the Management Board, Chief Executive Officer | ||
Dagmar Bottenbruch, Independent Member of the Supervisory Board | ||
Eric Jackson, Member of the Management Board and Presidentident of the AMG Processing Division, COO | ||
Donatella Ceccarelli, Independent Member of the Supervisory Board | ||
Willem Hassel, Independent Vice Chairman of the Supervisory Board | ||
Frank Lohner, Independent Member of the Supervisory Board | ||
Herbert Depp, Independent Member of the Supervisory Board | ||
Steve Hanke, Independent Chairman of the Supervisory Board |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 163.09 B | |||
Price To Book | 39.61 X | |||
Price To Sales | 5.64 X | |||
Revenue | 26.32 B | |||
EBITDA | 12.17 B | |||
Net Income | 6.55 B | |||
Total Debt | 37.35 B | |||
Cash Flow From Operations | 9.72 B | |||
Price To Earnings To Growth | 1.55 X | |||
Number Of Employees | 20 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.